Acta Chir Orthop Traumatol Cech. 2021; 88(4):321-324 | DOI: 10.55095/achot2021/048

Neoadjuvant Use of Isolated Limb Perfusion in Large Myxoid Liposarcoma of the Thigh: a Case ReportCase report

J. LESENSKÝ1,*, M. VOČKA2, M. ŠPAČEK3, M. HÓSOVÁ4
1 Ortopedická klinika, 1. lékařské fakulty Univerzity Karlovy, Fakultní nemocnice Na Bulovce a Institutu postgraduálního vzdělávání ve zdravotnictví, Praha
2 Klinika onkologie 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice v Praze
3 II. chirurgická klinika - kardiovaskulární chirurgie 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice v Praze
4 Ústav patologie 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Na Bulovce, Praha

Large unresectable STS presents a therapeutic challenge. Several options are being explored to avoid amputation without compromising the oncological outcome. Neoadjuvant chemotherapy delivers inconsistent and rather unsatisfactory results, preoperative radiotherapy compromises healing, hence it can impede adjuvant systemic treatment. We present a case report of neoadjuvant use of isolated limb perfusion with TNF-alfa and Alkeran (Melphalan) in a patient with initially unresectable large myxoid liposarcoma of the thigh. We achieved 55% reduction in size of the tumor that allowed for wide resection with a safe margin. Pathology confirmed 99% tumor necrosis. The patient has a full function of his extremity and is disease-free at one year follow-up. ILP should be considered as a treatment option which, in selected cases, can contribute to limb sparing surgery.

Keywords: sarcoma, soft tissue, regional perfusion, chemotherapy, surgery, orthopedic, limb salvage

Published: August 15, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
LESENSKÝ J, VOČKA M, ŠPAČEK M, HÓSOVÁ M. Neoadjuvant Use of Isolated Limb Perfusion in Large Myxoid Liposarcoma of the Thigh: a Case Report. Acta Chir Orthop Traumatol Cech. 2021;88(4):321-324. doi: 10.55095/achot2021/048. PubMed PMID: 34534063.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE. Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study. Eur J Surg Oncol. 2012;38:1178-1183. Go to original source... Go to PubMed...
    2. Baldini EH, Le Cesne A, Trent JC. Neoadjuvant chemotherapy, concurrent chemoradiation, and adjuvant chemotherapy for high-risk extremity soft tissue sarcoma. Am Soc Clin Oncol Educ Book. 2018;38:910-915. Go to original source... Go to PubMed...
    3. Beltrami G, Rüdiger HA, Mela MM, Scoccianti G, Livi L, Franchi A, Campanacci DA, Capanna R. Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas. Eur J Surg Oncol. 2008;34:811-816. Go to original source... Go to PubMed...
    4. Ferrone ML, Raut CP. Modern surgical therapy: limb salvage and the role of amputation for extremity soft-tissue sarcomas. Surg Oncol Clin N Am. 2012;21:201-213. Go to original source... Go to PubMed...
    5. Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18:812-822. Go to original source... Go to PubMed...
    6. Gronchi A, Hindi N, Cruz J, Blay JY, Lopez-Pousa A, Italiano A, Alvarez R, Gutierrez A, Rincón I, Sangalli C, Pérez Aguiar JL, Romero J, Morosi C, Sunyach MP, Sanfilippo R, Romagosa C, Ranchere-Vince D, Dei Tos AP, Casali PG, Martin-Broto J. Trabectedin and radiotherapy in soft tissue sarcoma (TRASTS): results of a phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups. EClinicalMedicine. 2019;9:35-43. Go to original source... Go to PubMed...
    7. Gui C, Morris CD, Meyer CF, Levin AS, Frassica DA, Deville C, Terezakis SA. Characterization and predictive value of volume changes of extremity and pelvis soft tissue sarcomas during radiation therapy prior to definitive wide excision. Radiat Oncol J. 2019;37:117-126. Go to original source... Go to PubMed...
    8. Jakob J, Hohenberger P. Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma. Cancer. 2016;122:2624-2632. Go to original source... Go to PubMed...
    9. Kalbasi A, Kamrava M, Chu FI, Telesca D, Van Dams R, Yang Y, Ruan D, Nelson SD, Dry SM, Hernandez J, Chmielowski B, Singh AS, Bukata SV, Bernthal NM, Steinberg ML, Weidhaas JB, Eilber FC. A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma. Clin Cancer Res. 2020;26:1829-1836. Go to original source... Go to PubMed...
    10. Klein J, Ghasem A, Huntley S, Donaldson N, Keisch M, Conway S. Does an algorithmic approach to using brachytherapy and external beam radiation result in good function, local control rates, and low morbidity in patients with extremity soft tissue sarcoma? Clin Orthop Relat Res. 2018;476:634-644. Go to original source... Go to PubMed...
    11. Ratan R, Patel SR. Chemotherapy for soft tissue sarcoma. Cancer. 2016;122:2952-2960. Go to original source... Go to PubMed...
    12. Setola E, Noujaim J, Benson C, Chawla S, Palmerini E, Jones RL. Eribulin in advanced liposarcoma and leiomyosarcoma. Expert Rev Anticancer Ther. 2017;17:717-723. Go to original source... Go to PubMed...
    13. Smith HG, Wilkinson MJ, Smith MJF, Strauss DC, Hayes AJ. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies. Eur J Cancer. 2018;100:46-54. Go to original source... Go to PubMed...
    14. Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH. Trends in the use of adjuvant chemotherapy for high-grade truncal and extremity soft tissue sarcomas. J Surg Res. 2020;245:577-586. Go to original source... Go to PubMed...
    15. Wilke B, Cooper A, Scarborough M, Gibbs P, Spiguel A. A comparison of limb salvage versus amputation for nonmetastatic sarcomas using patient-reported outcomes measurement information system outcomes. J Am Acad Orthop Surg. 2019;27:e381-e389. Go to original source... Go to PubMed...

    Return to the content